Motif ID: Pitx3
Z-value: 0.791
Transcription factors associated with Pitx3:
| Gene Symbol | Entrez ID | Gene Name |
|---|---|---|
| Pitx3 | ENSMUSG00000025229.9 | Pitx3 |
Top targets:
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.0 | 10.0 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
| 1.5 | 9.2 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 1.5 | 4.5 | GO:1902256 | endocardial cushion fusion(GO:0003274) apoptotic process involved in outflow tract morphogenesis(GO:0003275) atrial septum primum morphogenesis(GO:0003289) positive regulation of catagen(GO:0051795) regulation of apoptotic process involved in outflow tract morphogenesis(GO:1902256) |
| 1.1 | 3.4 | GO:0042275 | error-free postreplication DNA repair(GO:0042275) |
| 1.1 | 3.4 | GO:0021972 | corticospinal neuron axon guidance through spinal cord(GO:0021972) positive regulation of negative chemotaxis(GO:0050924) induction of negative chemotaxis(GO:0050929) negative regulation of mononuclear cell migration(GO:0071676) negative regulation of retinal ganglion cell axon guidance(GO:0090260) |
| 1.1 | 5.5 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
| 0.9 | 4.6 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
| 0.9 | 3.4 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
| 0.8 | 2.3 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
| 0.8 | 2.3 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
| 0.7 | 2.2 | GO:0070944 | neutrophil mediated killing of bacterium(GO:0070944) |
| 0.7 | 2.0 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
| 0.7 | 3.3 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
| 0.7 | 2.6 | GO:1902990 | mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
| 0.6 | 1.9 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
| 0.6 | 4.7 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
| 0.5 | 1.5 | GO:0090646 | RNA 5'-end processing(GO:0000966) mitochondrial tRNA processing(GO:0090646) |
| 0.5 | 1.5 | GO:0032650 | regulation of interleukin-1 alpha production(GO:0032650) positive regulation of interleukin-1 alpha production(GO:0032730) interleukin-1 alpha secretion(GO:0050703) regulation of bleb assembly(GO:1904170) |
| 0.5 | 1.4 | GO:0007525 | somatic muscle development(GO:0007525) |
| 0.5 | 1.4 | GO:1905223 | epicardium morphogenesis(GO:1905223) |
| 0.5 | 3.2 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.4 | 1.3 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
| 0.4 | 2.5 | GO:0003383 | apical constriction(GO:0003383) |
| 0.4 | 1.2 | GO:1903976 | negative regulation of glial cell migration(GO:1903976) |
| 0.4 | 1.2 | GO:0002865 | immune response-inhibiting signal transduction(GO:0002765) negative regulation of acute inflammatory response to antigenic stimulus(GO:0002865) |
| 0.4 | 1.9 | GO:0021764 | amygdala development(GO:0021764) |
| 0.4 | 2.3 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
| 0.4 | 1.1 | GO:0002925 | regulation of dendritic cell cytokine production(GO:0002730) positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) detection of peptidoglycan(GO:0032499) negative regulation of interleukin-18 production(GO:0032701) |
| 0.4 | 1.1 | GO:0036292 | DNA rewinding(GO:0036292) |
| 0.4 | 1.8 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
| 0.4 | 1.8 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
| 0.3 | 1.7 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
| 0.3 | 1.7 | GO:1902995 | apolipoprotein A-I-mediated signaling pathway(GO:0038027) regulation of phospholipid efflux(GO:1902994) positive regulation of phospholipid efflux(GO:1902995) |
| 0.3 | 1.7 | GO:2001168 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
| 0.3 | 2.3 | GO:0044838 | germ-line stem cell population maintenance(GO:0030718) cell quiescence(GO:0044838) |
| 0.3 | 0.3 | GO:0060854 | patterning of lymph vessels(GO:0060854) |
| 0.3 | 1.9 | GO:0036337 | Fas signaling pathway(GO:0036337) |
| 0.3 | 1.2 | GO:1990743 | protein sialylation(GO:1990743) |
| 0.3 | 1.2 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
| 0.3 | 1.5 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.3 | 1.1 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
| 0.3 | 1.1 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.3 | 3.8 | GO:0097502 | mannosylation(GO:0097502) |
| 0.3 | 0.8 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
| 0.3 | 1.5 | GO:0002317 | plasma cell differentiation(GO:0002317) |
| 0.2 | 0.7 | GO:0001180 | transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
| 0.2 | 2.0 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
| 0.2 | 0.7 | GO:1904975 | response to bleomycin(GO:1904975) cellular response to bleomycin(GO:1904976) |
| 0.2 | 0.7 | GO:0044837 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
| 0.2 | 1.2 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
| 0.2 | 0.9 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
| 0.2 | 1.2 | GO:0035547 | interferon-beta secretion(GO:0035546) regulation of interferon-beta secretion(GO:0035547) positive regulation of interferon-beta secretion(GO:0035549) CRD-mediated mRNA stabilization(GO:0070934) |
| 0.2 | 0.7 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
| 0.2 | 0.8 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 0.2 | 0.6 | GO:0048698 | negative regulation of collateral sprouting in absence of injury(GO:0048698) |
| 0.2 | 1.9 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
| 0.2 | 1.0 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.2 | 1.9 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
| 0.2 | 2.5 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
| 0.2 | 1.3 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
| 0.2 | 1.1 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
| 0.2 | 1.3 | GO:0070814 | hydrogen sulfide biosynthetic process(GO:0070814) |
| 0.2 | 1.8 | GO:1901409 | positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
| 0.2 | 0.9 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
| 0.2 | 2.0 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
| 0.2 | 1.1 | GO:0034587 | piRNA metabolic process(GO:0034587) |
| 0.2 | 0.5 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
| 0.2 | 0.5 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) regulation of interleukin-6-mediated signaling pathway(GO:0070103) negative regulation of interleukin-6-mediated signaling pathway(GO:0070104) |
| 0.2 | 1.3 | GO:1901162 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
| 0.2 | 0.5 | GO:0006667 | sphinganine metabolic process(GO:0006667) regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
| 0.1 | 14.8 | GO:0001824 | blastocyst development(GO:0001824) |
| 0.1 | 1.5 | GO:0097475 | motor neuron migration(GO:0097475) |
| 0.1 | 0.4 | GO:0018094 | protein polyglycylation(GO:0018094) |
| 0.1 | 0.6 | GO:0030043 | actin filament fragmentation(GO:0030043) |
| 0.1 | 2.1 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
| 0.1 | 3.6 | GO:0032967 | positive regulation of collagen biosynthetic process(GO:0032967) |
| 0.1 | 1.1 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.1 | 0.4 | GO:0090202 | regulation of primitive erythrocyte differentiation(GO:0010725) transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
| 0.1 | 0.5 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
| 0.1 | 0.8 | GO:1904953 | Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation(GO:1904953) |
| 0.1 | 1.7 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
| 0.1 | 1.2 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
| 0.1 | 0.8 | GO:1904217 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.1 | 0.3 | GO:0006272 | leading strand elongation(GO:0006272) DNA replication proofreading(GO:0045004) |
| 0.1 | 1.1 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
| 0.1 | 0.7 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
| 0.1 | 0.3 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
| 0.1 | 1.4 | GO:0002230 | positive regulation of defense response to virus by host(GO:0002230) |
| 0.1 | 1.9 | GO:0035855 | megakaryocyte development(GO:0035855) |
| 0.1 | 4.9 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
| 0.1 | 1.3 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.1 | 1.9 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.1 | 0.9 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
| 0.1 | 0.6 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
| 0.1 | 0.8 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
| 0.1 | 0.7 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
| 0.1 | 0.4 | GO:0019236 | response to pheromone(GO:0019236) |
| 0.1 | 2.2 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
| 0.1 | 0.8 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
| 0.1 | 0.9 | GO:0031272 | regulation of pseudopodium assembly(GO:0031272) |
| 0.1 | 1.4 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
| 0.1 | 2.2 | GO:0071539 | protein localization to centrosome(GO:0071539) |
| 0.1 | 0.6 | GO:0060613 | fat pad development(GO:0060613) |
| 0.1 | 1.0 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
| 0.1 | 2.3 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
| 0.1 | 1.1 | GO:0003334 | keratinocyte development(GO:0003334) |
| 0.1 | 0.7 | GO:0071763 | nuclear membrane organization(GO:0071763) |
| 0.1 | 0.8 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
| 0.1 | 2.6 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
| 0.1 | 0.4 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
| 0.1 | 1.2 | GO:0031297 | replication fork processing(GO:0031297) |
| 0.1 | 0.2 | GO:0016598 | protein arginylation(GO:0016598) |
| 0.1 | 0.2 | GO:0044313 | protein K6-linked deubiquitination(GO:0044313) |
| 0.1 | 0.5 | GO:0021940 | positive regulation of cerebellar granule cell precursor proliferation(GO:0021940) |
| 0.1 | 1.7 | GO:0006270 | DNA replication initiation(GO:0006270) |
| 0.1 | 1.4 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
| 0.1 | 0.3 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
| 0.1 | 0.3 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
| 0.0 | 1.5 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 0.0 | 3.1 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
| 0.0 | 2.2 | GO:0030819 | positive regulation of cAMP biosynthetic process(GO:0030819) |
| 0.0 | 2.0 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
| 0.0 | 3.5 | GO:0051225 | spindle assembly(GO:0051225) |
| 0.0 | 3.5 | GO:0007601 | visual perception(GO:0007601) |
| 0.0 | 0.7 | GO:0046069 | cGMP catabolic process(GO:0046069) |
| 0.0 | 1.3 | GO:0016572 | histone phosphorylation(GO:0016572) |
| 0.0 | 0.6 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
| 0.0 | 1.0 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.0 | 0.8 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
| 0.0 | 0.1 | GO:0046655 | dTMP biosynthetic process(GO:0006231) glycine biosynthetic process(GO:0006545) dTMP metabolic process(GO:0046073) folic acid metabolic process(GO:0046655) |
| 0.0 | 0.5 | GO:0003094 | glomerular filtration(GO:0003094) |
| 0.0 | 0.1 | GO:1901355 | response to rapamycin(GO:1901355) |
| 0.0 | 0.2 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
| 0.0 | 0.7 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
| 0.0 | 0.7 | GO:0043588 | skin development(GO:0043588) |
| 0.0 | 0.6 | GO:0051642 | centrosome localization(GO:0051642) |
| 0.0 | 0.8 | GO:0006998 | nuclear envelope organization(GO:0006998) |
| 0.0 | 0.1 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
| 0.0 | 2.1 | GO:0007338 | single fertilization(GO:0007338) |
| 0.0 | 0.2 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
| 0.0 | 0.9 | GO:0001702 | gastrulation with mouth forming second(GO:0001702) |
| 0.0 | 0.5 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
| 0.0 | 0.9 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
| 0.0 | 0.4 | GO:0007131 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
| 0.0 | 1.0 | GO:0048538 | thymus development(GO:0048538) |
| 0.0 | 1.9 | GO:0031110 | regulation of microtubule polymerization or depolymerization(GO:0031110) |
| 0.0 | 0.9 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
| 0.0 | 0.5 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
| 0.0 | 0.5 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
| 0.0 | 0.1 | GO:0043249 | erythrocyte maturation(GO:0043249) |
| 0.0 | 1.2 | GO:0035383 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
| 0.0 | 0.1 | GO:0001980 | regulation of systemic arterial blood pressure by ischemic conditions(GO:0001980) |
| 0.0 | 0.2 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
| 0.0 | 0.1 | GO:0045056 | transcytosis(GO:0045056) |
| 0.0 | 0.1 | GO:1900194 | negative regulation of oocyte development(GO:0060283) negative regulation of oocyte maturation(GO:1900194) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.2 | 3.6 | GO:0038045 | large latent transforming growth factor-beta complex(GO:0038045) |
| 1.1 | 3.4 | GO:0000802 | transverse filament(GO:0000802) |
| 1.1 | 3.4 | GO:0031372 | UBC13-MMS2 complex(GO:0031372) |
| 0.7 | 3.6 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
| 0.5 | 2.2 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
| 0.4 | 3.4 | GO:0070652 | HAUS complex(GO:0070652) |
| 0.4 | 1.2 | GO:0035101 | FACT complex(GO:0035101) |
| 0.3 | 2.7 | GO:0031415 | NatA complex(GO:0031415) |
| 0.3 | 2.5 | GO:0033269 | internode region of axon(GO:0033269) |
| 0.3 | 1.2 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
| 0.3 | 2.0 | GO:0071012 | catalytic step 1 spliceosome(GO:0071012) |
| 0.3 | 1.1 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
| 0.3 | 2.5 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
| 0.2 | 2.3 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
| 0.2 | 2.7 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
| 0.2 | 3.6 | GO:0031616 | spindle pole centrosome(GO:0031616) |
| 0.2 | 1.4 | GO:1990393 | 3M complex(GO:1990393) |
| 0.2 | 1.3 | GO:0001940 | male pronucleus(GO:0001940) |
| 0.2 | 1.7 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
| 0.2 | 1.2 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
| 0.2 | 1.2 | GO:0070187 | telosome(GO:0070187) |
| 0.2 | 1.9 | GO:0001673 | male germ cell nucleus(GO:0001673) |
| 0.2 | 0.5 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
| 0.1 | 1.9 | GO:0031209 | SCAR complex(GO:0031209) |
| 0.1 | 1.9 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
| 0.1 | 1.0 | GO:0089701 | U2AF(GO:0089701) |
| 0.1 | 2.0 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
| 0.1 | 2.6 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
| 0.1 | 1.7 | GO:0042555 | MCM complex(GO:0042555) |
| 0.1 | 0.8 | GO:0033503 | HULC complex(GO:0033503) |
| 0.1 | 1.8 | GO:0017119 | Golgi transport complex(GO:0017119) |
| 0.1 | 1.9 | GO:0036038 | MKS complex(GO:0036038) |
| 0.1 | 0.5 | GO:0035339 | SPOTS complex(GO:0035339) |
| 0.1 | 1.1 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
| 0.1 | 5.2 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
| 0.1 | 2.2 | GO:0016580 | Sin3 complex(GO:0016580) |
| 0.1 | 1.5 | GO:0033202 | DNA helicase complex(GO:0033202) |
| 0.1 | 1.4 | GO:0070938 | contractile ring(GO:0070938) |
| 0.1 | 1.3 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
| 0.1 | 0.4 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
| 0.1 | 0.8 | GO:1990909 | Wnt signalosome(GO:1990909) |
| 0.1 | 1.4 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
| 0.1 | 1.5 | GO:0001741 | XY body(GO:0001741) |
| 0.1 | 0.7 | GO:0090543 | Flemming body(GO:0090543) |
| 0.1 | 1.3 | GO:0042588 | zymogen granule(GO:0042588) |
| 0.1 | 2.9 | GO:0043596 | nuclear replication fork(GO:0043596) |
| 0.1 | 1.7 | GO:0001891 | phagocytic cup(GO:0001891) |
| 0.1 | 1.7 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
| 0.1 | 1.2 | GO:0035253 | ciliary rootlet(GO:0035253) |
| 0.1 | 1.8 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
| 0.1 | 1.3 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
| 0.1 | 5.1 | GO:0016605 | PML body(GO:0016605) |
| 0.1 | 1.6 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
| 0.1 | 5.5 | GO:0005604 | basement membrane(GO:0005604) |
| 0.0 | 0.2 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
| 0.0 | 0.1 | GO:1990047 | spindle matrix(GO:1990047) |
| 0.0 | 1.5 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
| 0.0 | 0.2 | GO:0032021 | NELF complex(GO:0032021) |
| 0.0 | 0.5 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
| 0.0 | 0.5 | GO:0030126 | COPI vesicle coat(GO:0030126) |
| 0.0 | 1.1 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
| 0.0 | 0.8 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
| 0.0 | 1.8 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
| 0.0 | 1.5 | GO:0016363 | nuclear matrix(GO:0016363) |
| 0.0 | 0.9 | GO:0031430 | M band(GO:0031430) |
| 0.0 | 0.1 | GO:0097512 | cardiac myofibril(GO:0097512) |
| 0.0 | 1.2 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
| 0.0 | 1.3 | GO:0008180 | COP9 signalosome(GO:0008180) |
| 0.0 | 0.4 | GO:0005652 | nuclear lamina(GO:0005652) |
| 0.0 | 0.9 | GO:0032040 | small-subunit processome(GO:0032040) |
| 0.0 | 0.9 | GO:0002102 | podosome(GO:0002102) |
| 0.0 | 0.2 | GO:0070847 | core mediator complex(GO:0070847) |
| 0.0 | 1.7 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
| 0.0 | 1.5 | GO:0031594 | neuromuscular junction(GO:0031594) |
| 0.0 | 0.9 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
| 0.0 | 2.2 | GO:0005903 | brush border(GO:0005903) |
| 0.0 | 0.1 | GO:0097447 | dendritic tree(GO:0097447) |
| 0.0 | 1.1 | GO:0072562 | blood microparticle(GO:0072562) |
| 0.0 | 1.0 | GO:0005811 | lipid particle(GO:0005811) |
| 0.0 | 0.5 | GO:0005882 | intermediate filament(GO:0005882) |
| 0.0 | 0.8 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.3 | 9.2 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
| 1.7 | 10.0 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
| 1.1 | 4.5 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
| 0.9 | 3.6 | GO:0050436 | microfibril binding(GO:0050436) |
| 0.8 | 2.5 | GO:0001156 | TFIIIC-class transcription factor binding(GO:0001156) |
| 0.8 | 4.0 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
| 0.8 | 3.9 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
| 0.6 | 1.7 | GO:0030226 | apolipoprotein receptor activity(GO:0030226) apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
| 0.5 | 1.5 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
| 0.4 | 1.3 | GO:0004510 | tryptophan 5-monooxygenase activity(GO:0004510) |
| 0.4 | 1.3 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
| 0.4 | 3.4 | GO:0048495 | GTPase inhibitor activity(GO:0005095) Roundabout binding(GO:0048495) |
| 0.4 | 2.0 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
| 0.4 | 2.0 | GO:0004661 | protein geranylgeranyltransferase activity(GO:0004661) |
| 0.4 | 2.3 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
| 0.4 | 5.7 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
| 0.3 | 2.1 | GO:0019841 | retinol binding(GO:0019841) |
| 0.3 | 0.9 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
| 0.3 | 0.9 | GO:0003979 | UDP-glucose 6-dehydrogenase activity(GO:0003979) |
| 0.3 | 2.0 | GO:0032184 | SUMO polymer binding(GO:0032184) |
| 0.3 | 1.1 | GO:0042834 | peptidoglycan binding(GO:0042834) |
| 0.3 | 2.2 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
| 0.3 | 2.1 | GO:0043559 | insulin binding(GO:0043559) |
| 0.3 | 2.6 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
| 0.3 | 1.3 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
| 0.3 | 0.8 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
| 0.2 | 0.7 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
| 0.2 | 1.2 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
| 0.2 | 0.7 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
| 0.2 | 0.9 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
| 0.2 | 1.4 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
| 0.2 | 1.2 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
| 0.2 | 2.2 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
| 0.2 | 1.2 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
| 0.2 | 1.5 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
| 0.2 | 2.7 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
| 0.2 | 0.5 | GO:0004923 | leukemia inhibitory factor receptor activity(GO:0004923) oncostatin-M receptor activity(GO:0004924) |
| 0.2 | 3.8 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
| 0.2 | 1.3 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
| 0.2 | 0.5 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
| 0.1 | 0.4 | GO:0070736 | protein-glycine ligase activity(GO:0070735) protein-glycine ligase activity, initiating(GO:0070736) |
| 0.1 | 1.2 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
| 0.1 | 2.5 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
| 0.1 | 0.3 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
| 0.1 | 1.1 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
| 0.1 | 2.0 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
| 0.1 | 0.7 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
| 0.1 | 0.3 | GO:0004936 | alpha-adrenergic receptor activity(GO:0004936) |
| 0.1 | 0.7 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
| 0.1 | 1.1 | GO:0036310 | annealing helicase activity(GO:0036310) |
| 0.1 | 1.7 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) histone demethylase activity (H3-K36 specific)(GO:0051864) |
| 0.1 | 1.9 | GO:0008373 | sialyltransferase activity(GO:0008373) |
| 0.1 | 0.7 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
| 0.1 | 1.9 | GO:0051787 | misfolded protein binding(GO:0051787) |
| 0.1 | 1.4 | GO:0017166 | vinculin binding(GO:0017166) |
| 0.1 | 1.0 | GO:0008301 | DNA binding, bending(GO:0008301) |
| 0.1 | 3.5 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
| 0.1 | 1.8 | GO:0042287 | MHC protein binding(GO:0042287) |
| 0.1 | 0.4 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
| 0.1 | 1.0 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
| 0.1 | 2.2 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
| 0.1 | 3.3 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
| 0.1 | 1.9 | GO:0070064 | proline-rich region binding(GO:0070064) |
| 0.1 | 1.3 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
| 0.1 | 0.7 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
| 0.1 | 1.1 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
| 0.1 | 0.6 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
| 0.1 | 0.8 | GO:0050692 | DBD domain binding(GO:0050692) |
| 0.0 | 0.1 | GO:0008732 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
| 0.0 | 0.6 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
| 0.0 | 2.3 | GO:0015485 | cholesterol binding(GO:0015485) |
| 0.0 | 0.5 | GO:0004177 | aminopeptidase activity(GO:0004177) |
| 0.0 | 1.8 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
| 0.0 | 0.7 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
| 0.0 | 2.0 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
| 0.0 | 2.0 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
| 0.0 | 0.9 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
| 0.0 | 1.3 | GO:0071837 | HMG box domain binding(GO:0071837) |
| 0.0 | 3.2 | GO:0002039 | p53 binding(GO:0002039) |
| 0.0 | 1.3 | GO:0005507 | copper ion binding(GO:0005507) |
| 0.0 | 0.7 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
| 0.0 | 2.4 | GO:0034212 | peptide N-acetyltransferase activity(GO:0034212) |
| 0.0 | 1.2 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
| 0.0 | 1.6 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
| 0.0 | 0.5 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
| 0.0 | 0.1 | GO:0030172 | troponin C binding(GO:0030172) |
| 0.0 | 0.8 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
| 0.0 | 1.3 | GO:0097472 | cyclin-dependent protein kinase activity(GO:0097472) |
| 0.0 | 0.3 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
| 0.0 | 1.5 | GO:0001076 | transcription factor activity, RNA polymerase II transcription factor binding(GO:0001076) |
| 0.0 | 3.2 | GO:0004386 | helicase activity(GO:0004386) |
| 0.0 | 0.9 | GO:0005109 | frizzled binding(GO:0005109) |
| 0.0 | 2.4 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
| 0.0 | 0.2 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
| 0.0 | 1.2 | GO:0042393 | histone binding(GO:0042393) |
| 0.0 | 0.3 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
| 0.0 | 0.2 | GO:0003688 | DNA replication origin binding(GO:0003688) |
| 0.0 | 0.9 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
| 0.0 | 0.7 | GO:0001671 | ATPase activator activity(GO:0001671) |
| 0.0 | 2.9 | GO:0017124 | SH3 domain binding(GO:0017124) |
| 0.0 | 0.3 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
| 0.0 | 0.4 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
| 0.0 | 0.8 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
| 0.0 | 0.1 | GO:0003680 | AT DNA binding(GO:0003680) |
| 0.0 | 16.4 | GO:0003700 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
| 0.0 | 3.0 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
| 0.0 | 0.9 | GO:0005125 | cytokine activity(GO:0005125) |
Gene overrepresentation in C2:CP category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.5 | 4.5 | SA_MMP_CYTOKINE_CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
| 0.2 | 4.7 | PID_GLYPICAN_1PATHWAY | Glypican 1 network |
| 0.1 | 1.3 | SA_REG_CASCADE_OF_CYCLIN_EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
| 0.1 | 3.6 | PID_AURORA_A_PATHWAY | Aurora A signaling |
| 0.1 | 2.6 | PID_FOXM1_PATHWAY | FOXM1 transcription factor network |
| 0.1 | 3.0 | ST_WNT_BETA_CATENIN_PATHWAY | Wnt/beta-catenin Pathway |
| 0.1 | 0.7 | PID_RHODOPSIN_PATHWAY | Visual signal transduction: Rods |
| 0.1 | 2.3 | PID_BARD1_PATHWAY | BARD1 signaling events |
| 0.1 | 2.9 | PID_THROMBIN_PAR1_PATHWAY | PAR1-mediated thrombin signaling events |
| 0.1 | 0.8 | PID_BETA_CATENIN_DEG_PATHWAY | Degradation of beta catenin |
| 0.1 | 1.1 | PID_NFKAPPAB_CANONICAL_PATHWAY | Canonical NF-kappaB pathway |
| 0.1 | 1.7 | PID_ARF6_PATHWAY | Arf6 signaling events |
| 0.1 | 3.0 | PID_ERBB4_PATHWAY | ErbB4 signaling events |
| 0.0 | 1.8 | SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES | Genes related to the insulin receptor pathway |
| 0.0 | 2.4 | PID_ILK_PATHWAY | Integrin-linked kinase signaling |
| 0.0 | 0.9 | PID_ATR_PATHWAY | ATR signaling pathway |
| 0.0 | 1.5 | NABA_PROTEOGLYCANS | Genes encoding proteoglycans |
| 0.0 | 1.2 | ST_B_CELL_ANTIGEN_RECEPTOR | B Cell Antigen Receptor |
| 0.0 | 0.8 | SA_PROGRAMMED_CELL_DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
| 0.0 | 1.5 | PID_FOXO_PATHWAY | FoxO family signaling |
| 0.0 | 0.5 | PID_IL27_PATHWAY | IL27-mediated signaling events |
| 0.0 | 1.9 | PID_CASPASE_PATHWAY | Caspase cascade in apoptosis |
| 0.0 | 1.9 | PID_RAC1_PATHWAY | RAC1 signaling pathway |
| 0.0 | 1.0 | NABA_BASEMENT_MEMBRANES | Genes encoding structural components of basement membranes |
| 0.0 | 0.6 | ST_G_ALPHA_I_PATHWAY | G alpha i Pathway |
| 0.0 | 2.7 | NABA_ECM_GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
| 0.0 | 1.2 | PID_TELOMERASE_PATHWAY | Regulation of Telomerase |
| 0.0 | 1.3 | PID_AR_PATHWAY | Coregulation of Androgen receptor activity |
Gene overrepresentation in C2:CP:REACTOME category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.3 | 2.6 | REACTOME_REMOVAL_OF_THE_FLAP_INTERMEDIATE_FROM_THE_C_STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
| 0.2 | 1.5 | REACTOME_THE_NLRP3_INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
| 0.2 | 3.4 | REACTOME_ACTIVATION_OF_RAC | Genes involved in Activation of Rac |
| 0.2 | 1.6 | REACTOME_ACYL_CHAIN_REMODELLING_OF_PI | Genes involved in Acyl chain remodelling of PI |
| 0.2 | 1.1 | REACTOME_REGULATION_OF_ORNITHINE_DECARBOXYLASE_ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
| 0.2 | 2.6 | REACTOME_CYCLIN_A_B1_ASSOCIATED_EVENTS_DURING_G2_M_TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
| 0.1 | 3.8 | REACTOME_SYNTHESIS_OF_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
| 0.1 | 1.3 | REACTOME_KERATAN_SULFATE_DEGRADATION | Genes involved in Keratan sulfate degradation |
| 0.1 | 1.3 | REACTOME_AMINE_DERIVED_HORMONES | Genes involved in Amine-derived hormones |
| 0.1 | 1.3 | REACTOME_DOWNREGULATION_OF_TGF_BETA_RECEPTOR_SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
| 0.1 | 7.5 | REACTOME_MEIOTIC_SYNAPSIS | Genes involved in Meiotic Synapsis |
| 0.1 | 0.9 | REACTOME_GLUCURONIDATION | Genes involved in Glucuronidation |
| 0.1 | 1.3 | REACTOME_VITAMIN_B5_PANTOTHENATE_METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
| 0.1 | 2.0 | REACTOME_BRANCHED_CHAIN_AMINO_ACID_CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
| 0.1 | 1.7 | REACTOME_ABCA_TRANSPORTERS_IN_LIPID_HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
| 0.1 | 0.6 | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
| 0.1 | 2.5 | REACTOME_TIGHT_JUNCTION_INTERACTIONS | Genes involved in Tight junction interactions |
| 0.1 | 0.8 | REACTOME_IL_7_SIGNALING | Genes involved in Interleukin-7 signaling |
| 0.1 | 6.7 | REACTOME_GLYCEROPHOSPHOLIPID_BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
| 0.1 | 1.2 | REACTOME_N_GLYCAN_ANTENNAE_ELONGATION | Genes involved in N-Glycan antennae elongation |
| 0.1 | 1.1 | REACTOME_INTEGRATION_OF_PROVIRUS | Genes involved in Integration of provirus |
| 0.1 | 4.3 | REACTOME_GOLGI_ASSOCIATED_VESICLE_BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
| 0.1 | 2.6 | REACTOME_GLUCAGON_TYPE_LIGAND_RECEPTORS | Genes involved in Glucagon-type ligand receptors |
| 0.1 | 0.7 | REACTOME_CALNEXIN_CALRETICULIN_CYCLE | Genes involved in Calnexin/calreticulin cycle |
| 0.1 | 2.2 | REACTOME_NUCLEAR_SIGNALING_BY_ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
| 0.1 | 1.1 | REACTOME_ACTIVATED_TAK1_MEDIATES_P38_MAPK_ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
| 0.1 | 0.5 | REACTOME_IL_6_SIGNALING | Genes involved in Interleukin-6 signaling |
| 0.1 | 2.3 | REACTOME_MRNA_3_END_PROCESSING | Genes involved in mRNA 3'-end processing |
| 0.1 | 4.4 | REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2_ | Genes involved in Response to elevated platelet cytosolic Ca2+ |
| 0.0 | 0.5 | REACTOME_COPI_MEDIATED_TRANSPORT | Genes involved in COPI Mediated Transport |
| 0.0 | 2.2 | REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
| 0.0 | 0.8 | REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
| 0.0 | 1.5 | REACTOME_HS_GAG_BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
| 0.0 | 1.7 | REACTOME_SPHINGOLIPID_DE_NOVO_BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
| 0.0 | 3.3 | REACTOME_G_ALPHA1213_SIGNALLING_EVENTS | Genes involved in G alpha (12/13) signalling events |
| 0.0 | 0.5 | REACTOME_RNA_POL_III_CHAIN_ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
| 0.0 | 2.2 | REACTOME_LOSS_OF_NLP_FROM_MITOTIC_CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
| 0.0 | 2.7 | REACTOME_MRNA_SPLICING | Genes involved in mRNA Splicing |
| 0.0 | 0.5 | REACTOME_REGULATION_OF_AMPK_ACTIVITY_VIA_LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
| 0.0 | 0.7 | REACTOME_CGMP_EFFECTS | Genes involved in cGMP effects |
| 0.0 | 1.4 | REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
| 0.0 | 2.7 | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | Genes involved in G alpha (i) signalling events |
| 0.0 | 0.2 | REACTOME_PASSIVE_TRANSPORT_BY_AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
| 0.0 | 0.3 | REACTOME_HORMONE_SENSITIVE_LIPASE_HSL_MEDIATED_TRIACYLGLYCEROL_HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
| 0.0 | 0.9 | REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
| 0.0 | 1.2 | REACTOME_RNA_POL_I_RNA_POL_III_AND_MITOCHONDRIAL_TRANSCRIPTION | Genes involved in RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription |
| 0.0 | 0.5 | REACTOME_ACTIVATION_OF_THE_PRE_REPLICATIVE_COMPLEX | Genes involved in Activation of the pre-replicative complex |
| 0.0 | 1.4 | REACTOME_MITOTIC_PROMETAPHASE | Genes involved in Mitotic Prometaphase |
| 0.0 | 0.2 | REACTOME_ELONGATION_ARREST_AND_RECOVERY | Genes involved in Elongation arrest and recovery |
| 0.0 | 1.1 | REACTOME_SIGNALING_BY_RHO_GTPASES | Genes involved in Signaling by Rho GTPases |
